NCT00309335View on ClinicalTrials.gov

Study of NV-101 for Efficacy, Pharmacodynamics, and Safety in Dental Patients Undergoing Maxillary Procedures

PHASE3CompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

February 28, 2006

Study Completion Date

July 31, 2006

Conditions
Anesthesia, Dental
Interventions
DRUG

Phentolamine Mesylate (NV-101)

Trial Locations (1)

02111

Tufts University School of Dental Medicine, Boston

Sponsors
All Listed Sponsors
lead

Novalar Pharmaceuticals, Inc.

INDUSTRY